Patti Melick chairs the life science practice at Wiggin and Dana LLP focusing on merger and acquisition transactions within the life sciences industry. Melick has represented multinational pharmaceutical and biotechnology companies in cross-border transactions, clinical trial agreements and licensing deals.
Legal 500 Editorial commentary
Phone
+1 857 491 9643
Email
Social

Accolades

Boston Elite

Profile

Work Department
Clinical Research, Corporate, Emerging Companies and Venture Capital, Intellectual Property, Life Sciences, Mergers and Acquisitions, Private Equity
Position

Partner

Career

Patti is an accomplished life sciences lawyer who has helped numerous clients grow and bring their innovations to market over her almost 30-year career at Wiggin and Dana. She is Chair of the Life Sciences Practice and a Partner in the firm’s Corporate Department and the Mergers and Acquisitions Practice. Patti is also a member of the firm’s Pro Bono Committee and a past member of the firm’s Executive Committee. She is also a member of wiggin(x).

Patti’s work has earned multiple honors and recognition, including consistently being named a “Life Science Star” for mergers and acquisitions and for licensing and collaborations in LMG Life Sciences, Finance Monthly’s Deal Maker of the Year, and the Pro Bono Partnership’s Volunteer of the Year. She is also a James W. Cooper Fellow of the Connecticut Bar Foundation and former Vice-Chair of Women in Bio’s Metro New York Chapter.

Her extensive experience spans large multinational pharmaceutical, biotechnology, and medical device companies to world-class universities, emerging biotechnology companies, scientists, and entrepreneurs. She counsels clients in cross-border mergers and acquisitions, global licenses and strategic alliances, research and development arrangements, including clinical trial programs, manufacturing agreements and other commercial contracts.

Before joining Wiggin and Dana, Patti practiced law in the New York office of the Swedish law firm Mannheimer Swartling.

She received her J.D. from the University of Chicago Law School and graduated summa cum laude and Phi Beta Kappa from Lehigh University.

Education
  • University of Chicago Law School (J.D., 1987)
  • Lehigh University (B.A., 1984)
    • Phi Beta Kappa
    • summa cum laude

Content supplied by Wiggin and Dana LLP

Key clients

  • AptarGroup Inc.

Work highlights

Represented Aptar Pharma, in its acquisition of the clinical trial materials manufacturing capabilities of Mod3 Pharma from SWK Holdings